Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × spartalizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Pheochromocytoma 1 Paraganglioma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharangeal Cancer 1 Lung Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1 Hereditary leiomyomatosis and renal cell cancer 1 Hemangiosarcoma 1 Glioma 1 Fibrolamellar hepatocellular carcinoma 1 Esophageal Squamous Cell Carcinoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

pembrolizumab 27 enfortumab vedotin 16 Nivolumab 14 Gemcitabine 12 avelumab 10 Magnetic Resonance Spectroscopy 10 Cisplatin 10 Carboplatin 10 Specimen Handling 9 sacituzumab govitecan 6 atezolizumab 6 durvalumab 5 Ipilimumab 5 Docetaxel 5 Paclitaxel 4 cabozantinib 3 Taxes 3 tislelizumab 2 relatlimab 2 lenvatinib 2 erdafitinib 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Cryosurgery 2 CTLA-4 Antigen 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡